PRICE T ROWE ASSOCIATES INC /MD/
CIK 000008025518 SPACs with a current declared position, filed between Dec 10, 2020 and Nov 14, 2024. 0 of them were re-affirmed in the last 12 months. The rest are the filer’s last word on a position, not proof it is still held: an amendment is only required on a material change, so a fund that sells below 5% may never file again.
This filer has not filed a Schedule 13 on any SPAC since Nov 14, 2024. Read the page below as a record of what was declared, not as a register of what is held.
Positions
one row per SPAC — every figure read from the accession in the Source column| SPAC | Voting | Dispositive | Source | |||||
|---|---|---|---|---|---|---|---|---|
| BSKY | Big Sky Growth Partners, Inc. | 14.6% | 4,388,156 | 1,185,310 / 0 | 4,388,156 / 0 | Liquidated | Feb 14, 2022Stale | SC 13G/A0000080255-22-002262 1 earlier statement |
| AGC | Altimeter Growth Corp. | 14.1% | 7,057,900 | 3,878,564 / 0 | 7,057,900 / 0 | Closed (deSPAC) | May 10, 2021Stale | SC 13G0000080255-21-001404 |
| CPAA | Conyers Park III Acquisition Corp. | 12.0% | 4,303,291 | 1,154,899 / 0 | 4,303,291 / 0 | Liquidated | Feb 14, 2022Stale | SC 13G/A0000080255-22-002271 1 earlier statement |
| DYNS | Senti Biosciences Holdings, Inc.2 reporting persons on this schedule | 8.1% | 3,554,017 | 1,457,918 / 0 | 3,231,873 / 0 | Closed (deSPAC) | Feb 14, 2023Stale | SC 13G0000080255-23-002743 1 earlier statement |
| HLXB | Helix Acquisition Corp. II | 6.0% | 1,127,598 | 1,127,598 / 0 | 1,127,598 / 0 | Closed (deSPAC) | Nov 14, 2024Stale | SC 13G0000080255-24-001487 |
| EUCR | Eucrates Biomedical Acquisition Corp. | 5.4% | 730,864 | 80,977 / 0 | 730,864 / 0 | Liquidated | Feb 14, 2022Stale | SC 13G0000080255-22-002250 |
| HSAQ | Health Sciences Acquisitions Corp 22 reporting persons on this schedule | 5.0% | 622,608 | 562,163 / 0 | 622,608 / 0 | Closed (deSPAC) | Feb 14, 2024Stale | SC 13G0000080255-24-000759 1 earlier statement |
| KVSB | Khosla Ventures Acquisition Co. II2 reporting persons on this schedule | 4.2% | 3,359,809 | 3,359,809 / 0 | 1,405,839 / 0 | Closed (deSPAC) | Feb 10, 2022Stale | SC 13G/A0000080255-22-000963 3 earlier statements |
| ARYB | ARYA Sciences Acquisition Corp II3 reporting persons on this schedule | 2.8% | 3,639,190 | 1,480,595 / 0 | 3,639,190 / 0 | Closed (deSPAC) | Dec 10, 2020Stale | SC 13G/A0000080255-20-001736 3 earlier statements |
| CCXX | Butler Acquisition Corp2 reporting persons on this schedule | 2.1% | 14,306,500 | 14,306,500 / 0 | 322,460 / 0 | Closed (deSPAC) | Feb 14, 2023Stale | SC 13G/A0000080255-23-002714 7 earlier statements |
| HLXA | Helix Acquisition Corp2 reporting persons on this schedule | 2.1% | 822,601 | 104,888 / 0 | 822,601 / 0 | Closed (deSPAC) | Feb 14, 2023Stale | SC 13G/A0000080255-23-002729 3 earlier statements |
| FSII | FS Development Corp. II2 reporting persons on this schedule | 1.9% | 1,237,291 | 1,237,291 / 0 | 6,166 / 0 | Closed (deSPAC) | Feb 14, 2023Stale | SC 13G/A0000080255-23-002735 3 earlier statements |
| RTPY | Reinvent Technology Partners Y | 1.8% | 23,402,815 | 22,048,038 / 0 | 23,504,302 / 0 | Closed (deSPAC) | Nov 14, 2024Stale | SC 13G/A0000080255-24-001472 3 earlier statements |
| IPOB | Social Capital Hedosophia Holdings Corp. II | 0.4% | 2,570,301 | 687,809 / 0 | 2,570,301 / 0 | Closed (deSPAC) | Feb 14, 2023Stale | SC 13G/A0000080255-23-002726 1 earlier statement |
| BOAC | Bluescape Opportunities Acquisition Corp. | 0.0% | 0 | 0 / 0 | 0 / 0 | Liquidated | Oct 11, 2022Stale | SC 13G/A0000080255-22-002557 1 earlier statement |
| CCH | Collier Creek Holdings | 0.0% | 29,004 | 23,804 / 0 | 29,004 / 0 | Closed (deSPAC) | Feb 14, 2023Stale | SC 13G/A0000080255-23-002717 5 earlier statements |
| SAIL | Revolution Healthcare Acquisition Corp. | 0.0% | 0 | 0 / 0 | 0 / 0 | Liquidated | Dec 12, 2022Stale | SC 13G/A0000080255-22-002575 1 earlier statement |
| RACA | Therapeutics Acquisition Corp. | not stated | 0 | 0 / 0 | 0 / 0 | Closed (deSPAC) | Feb 14, 2022Stale | SC 13G/A0000080255-22-001838 1 earlier statement |
35 superseded statements (newest 28 shown)
An amendment replaces a stake as current; it never erases the record of it. These are the earlier statements, each with the accession that replaced it — kept because “what did this filer say in 2022” is a different question from “what does it say now”, and only the second one has an answer above.
- RTPY Reinvent Technology Partners Y5.2% · SC 13G Feb 14, 2024replaced Nov 14, 2024 by 0000080255-24-001472
- RTPY Reinvent Technology Partners Y0.0% · SC 13G/A Feb 14, 2023replaced Feb 14, 2024 by 0000080255-24-000768
- HSAQ Health Sciences Acquisitions Corp 26.1% · SC 13G Feb 14, 2023replaced Feb 14, 2024 by 0000080255-24-000759
- BOAC Bluescape Opportunities Acquisition Corp.8.9% · SC 13G Feb 14, 2022replaced Oct 11, 2022 by 0000080255-22-002557
- CCXX Butler Acquisition Corp5.7% · SC 13G/A Feb 14, 2022replaced Feb 14, 2023 by 0000080255-23-002714
- IPOB Social Capital Hedosophia Holdings Corp. II5.9% · SC 13G Feb 14, 2022replaced Feb 14, 2023 by 0000080255-23-002726
- HLXA Helix Acquisition Corp6.2% · SC 13G/A Feb 14, 2022replaced Feb 14, 2023 by 0000080255-23-002729
- CCH Collier Creek Holdings9.5% · SC 13G/A Feb 14, 2022replaced Feb 14, 2023 by 0000080255-23-002717
- SAIL Revolution Healthcare Acquisition Corp.9.0% · SC 13G Feb 14, 2022replaced Dec 12, 2022 by 0000080255-22-002575
- RTPY Reinvent Technology Partners Y8.7% · SC 13G Feb 14, 2022replaced Feb 14, 2023 by 0000080255-23-002744
- KVSB Khosla Ventures Acquisition Co. II13.7% · SC 13G/A Feb 10, 2022replaced Feb 10, 2022 by 0000080255-22-000974
- FSII FS Development Corp. II5.1% · SC 13G/A Jan 10, 2022replaced Feb 14, 2023 by 0000080255-23-002735
- FSII FS Development Corp. II12.2% · SC 13G Dec 13, 2021replaced Jan 10, 2022 by 0000080255-22-000016
- CPAA Conyers Park III Acquisition Corp.12.3% · SC 13G Sep 10, 2021replaced Feb 14, 2022 by 0000080255-22-002271
- KVSB Khosla Ventures Acquisition Co. II11.6% · SC 13G Aug 10, 2021replaced Feb 10, 2022 by 0000080255-22-000963
- DYNS Senti Biosciences Holdings, Inc.12.6% · SC 13G Jun 10, 2021replaced Feb 14, 2023 by 0000080255-23-002743
- BSKY Big Sky Growth Partners, Inc.15.0% · SC 13G May 10, 2021replaced Feb 14, 2022 by 0000080255-22-002262
- RACA Therapeutics Acquisition Corp.5.2% · SC 13G Feb 16, 2021replaced Feb 14, 2022 by 0000080255-22-001838
- HLXA Helix Acquisition Corp5.3% · SC 13G Feb 16, 2021replaced Feb 14, 2022 by 0000080255-22-002249
- CCH Collier Creek Holdings13.1% · SC 13G Feb 16, 2021replaced Feb 14, 2022 by 0000080255-22-002232
- CCXX Butler Acquisition Corp5.0% · SC 13G Feb 16, 2021replaced Feb 14, 2022 by 0000080255-22-002229
- CCXX Butler Acquisition Corp4.6% · SC 13G/A Nov 10, 2020replaced Feb 16, 2021 by 0000080255-21-001339
- ARYB ARYA Sciences Acquisition Corp II18.7% · SC 13G Nov 10, 2020replaced Dec 10, 2020 by 0000080255-20-001736
- CCXX Butler Acquisition Corp16.3% · SC 13G/A Oct 13, 2020replaced Nov 10, 2020 by 0000080255-20-001706
- CCXX Butler Acquisition Corp11.0% · SC 13G Sep 10, 2020replaced Oct 13, 2020 by 0000080255-20-001678
- CCH Collier Creek Holdings11.7% · SC 13G/A Feb 14, 2020replaced Feb 16, 2021 by 0000080255-21-001340
- CCH Collier Creek Holdings11.5% · SC 13G/A Feb 14, 2019replaced Feb 14, 2020 by 0000080255-20-001364
- CCH Collier Creek Holdings11.5% · SC 13G Nov 13, 2018replaced Feb 14, 2019 by 0000080255-19-002760
Reporting persons on this filer's schedules
one filer, several names — collapsed once, shown in fullA joint Schedule 13 names every person who beneficially owns the shares — the management company, the funds it advises, the general partner and often the individual who controls all three. They report the same shares. Counting them separately would publish this filer’s footprint two or three times over, so they are counted once, under CIK 0000080255. This filer has named 5 of them across the schedules in the table above:
- T. Rowe Price Associates, Inc. 52-0556948
- T. Rowe Price Global Technology Fund 52-2279218
- T. Rowe Price Health Sciences Fund, Inc. 52-1952906
- T. Rowe Price Mid-Cap Growth Fund, Inc. 52-1784828
- T. Rowe Price New Horizons Fund, Inc. 52-0791372
Appears alongside
other filers with a current declared position in the same SPACsCo-occurrence in the disclosure record, and nothing more. It is not evidence of a group, an agreement or acting in concert — filers who act as a group say so on the cover page and file a 13D. Two arbitrage funds above 5% in the same shell is the ordinary shape of this market. The second number restricts both sides to statements filed in the last 12 months, because a 2021 stake beside a 2026 one is two facts about two different years.
- BlackRock Inc.5 SPACs · 0 fresh
- CITADEL ADVISORS LLC5 SPACs · 0 fresh
- MORGAN STANLEY5 SPACs · 0 fresh
- VANGUARD GROUP INC5 SPACs · 0 fresh
- BlackRock, Inc.4 SPACs · 0 fresh
- RA CAPITAL MANAGEMENT, L.P.4 SPACs · 0 fresh
- T. Rowe Price Investment Management, Inc.4 SPACs · 0 fresh
- ADAGE CAPITAL PARTNERS GP, L.L.C.3 SPACs · 0 fresh
- INTEGRATED CORE STRATEGIES (US) LLC3 SPACs · 0 fresh
- PERCEPTIVE ADVISORS LLC3 SPACs · 0 fresh
- ARK Investment Management LLC2 SPACs · 0 fresh
- BIOTECHNOLOGY VALUE FUND L P2 SPACs · 0 fresh
- FMR LLC2 SPACs · 0 fresh
- HGC Investment Management Inc.2 SPACs · 0 fresh
- JPMORGAN CHASE & CO2 SPACs · 0 fresh
- MILLENNIUM MANAGEMENT LLC2 SPACs · 0 fresh
- RTW INVESTMENTS, LP2 SPACs · 0 fresh
- SB INVESTMENT ADVISERS (UK) LTD2 SPACs · 0 fresh
- Sculptor Capital LP2 SPACs · 0 fresh
- SUVRETTA CAPITAL MANAGEMENT, LLC2 SPACs · 0 fresh
- VK Services, LLC2 SPACs · 0 fresh
- WELLINGTON MANAGEMENT GROUP LLP2 SPACs · 0 fresh
- 683 Capital Management, LLC1 SPAC · 0 fresh
- ACCESS INDUSTRIES MANAGEMENT, LLC1 SPAC · 0 fresh
Every percentage above is the one printed on the cover page of the filing cited beside it — a percentage of the shares outstanding on that date. A SPAC’s float collapses at each redemption, so two of these percentages are percentages of two different companies and they do not add. Rows are one per SPAC: where a joint schedule names several reporting persons, the largest single figure is shown rather than their sum, because a manager and the funds it advises beneficially own the same shares. Nothing on this page is derived from a 13F, a vendor holdings file or a press release. See how this is built.